| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Chu Chen | |
| Jian-Yi Xu | |||
| P2860 | cites work | The spectrum of disease in chronic traumatic encephalopathy | Q22242925 |
| Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations | Q24309438 | ||
| Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 | ||
| Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path | Q24538964 | ||
| Long-lasting potentiation of synaptic transmission in the dentate area of the unanaestetized rabbit following stimulation of the perforant path | Q24538966 | ||
| Persistent synaptic activity produces long-lasting enhancement of endocannabinoid modulation and alters long-term synaptic plasticity | Q48225806 | ||
| Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region. | Q48287373 | ||
| Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels | Q48518739 | ||
| Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids | Q48618242 | ||
| Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. | Q51411852 | ||
| Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish | Q55871276 | ||
| Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism | Q72890729 | ||
| Dopamine, serotonin, and noradrenaline strongly inhibit the direct perforant path-CA1 synaptic input, but have little effect on the Schaffer collateral input | Q74057649 | ||
| Inflammation in Parkinson's disease | Q84590489 | ||
| Cannabinoid receptor localization in brain | Q24558751 | ||
| Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects | Q24569799 | ||
| CB2 receptors in the brain: role in central immune function | Q24643895 | ||
| A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol | Q24649418 | ||
| A biosynthetic pathway for anandamide | Q24671032 | ||
| Therapeutic potential of monoacylglycerol lipase inhibitors | Q26991513 | ||
| Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers | Q26995259 | ||
| Role of endogenous cannabinoids in synaptic signaling | Q28185075 | ||
| Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains | Q28189423 | ||
| Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets | Q28203208 | ||
| CB1 cannabinoid receptors and on-demand defense against excitotoxicity | Q28207143 | ||
| Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells | Q28212245 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus | Q28268567 | ||
| Endocannabinoid-mediated metaplasticity in the hippocampus | Q28281747 | ||
| Role for a cortical input to hippocampal area CA1 in the consolidation of a long-term memory | Q28286699 | ||
| 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 | ||
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
| Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ | Q28298445 | ||
| Chronic neuropathologies of single and repetitive TBI: substrates of dementia? | Q28384302 | ||
| Functional CB2 type cannabinoid receptors at CNS synapses | Q28575031 | ||
| Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice | Q28591248 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
| Long-term potentiation of perforant path synapses in hippocampal CA1 in vitro | Q30467659 | ||
| The three-dimensional organization of the hippocampal formation: a review of anatomical data | Q31045849 | ||
| Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex | Q33293523 | ||
| Endocannabinoids differentially modulate synaptic plasticity in rat hippocampal CA1 pyramidal neurons | Q33565499 | ||
| Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism | Q33840797 | ||
| Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. | Q33845285 | ||
| A cortical-hippocampal system for declarative memory | Q33938394 | ||
| Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses | Q33940688 | ||
| Biology of endocannabinoid synthesis system | Q34015534 | ||
| Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens | Q34032832 | ||
| An endogenous cannabinoid (2-AG) is neuroprotective after brain injury | Q34093755 | ||
| The endocannabinoid system as a target for the treatment of neurodegenerative disease | Q34098196 | ||
| Novel natural and synthetic ligands of the endocannabinoid system | Q34099509 | ||
| Endocannabinoid signaling in the brain | Q34125520 | ||
| Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders | Q34126096 | ||
| Synaptic stability and plasticity in a floating world. | Q34127724 | ||
| Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids | Q34166712 | ||
| Lamellar organization of hippocampal pathways | Q34236017 | ||
| Cerebellar long-term depression: characterization, signal transduction, and functional roles | Q34294070 | ||
| Endocannabinoid signaling and synaptic function | Q34304094 | ||
| Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling | Q34387254 | ||
| Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. | Q34397288 | ||
| Chronic traumatic encephalopathy in a National Football League player | Q34429904 | ||
| Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex | Q34515044 | ||
| Prostaglandins and leukotrienes as inflammatory mediators | Q34552647 | ||
| Chronic traumatic encephalopathy - neuropathology in athletes and war veterans | Q34619302 | ||
| Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults | Q34642593 | ||
| Chronic traumatic encephalopathy | Q34660999 | ||
| Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance | Q34673072 | ||
| Molecular reorganization of endocannabinoid signalling in Alzheimer's disease | Q34754667 | ||
| PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms | Q34864285 | ||
| Emerging roles of PPARs in inflammation and immunity | Q34931884 | ||
| Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. | Q35008120 | ||
| Neuroinflammation and memory: the role of prostaglandins | Q35072707 | ||
| Endocannabinoids and traumatic brain injury | Q35193282 | ||
| Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. | Q35193317 | ||
| Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation | Q35645037 | ||
| Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE) | Q35752220 | ||
| Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood | Q35885458 | ||
| Spike timing-dependent plasticity of neural circuits. | Q35902473 | ||
| Cannabinoid receptors and their role in neuroprotection | Q36211444 | ||
| Cannabinoids: between neuroprotection and neurotoxicity | Q36352209 | ||
| Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease | Q36442881 | ||
| A light and electron microscopic analysis of the mossy fibers of the rat dentate gyrus | Q36474952 | ||
| Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders | Q36497184 | ||
| Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus | Q36498521 | ||
| Endocannabinoid-mediated synaptic plasticity in the CNS. | Q36507561 | ||
| The cannabinoid receptor: biochemical, anatomical and behavioral characterization | Q36605535 | ||
| The endocannabinoid system in targeting inflammatory neurodegenerative diseases | Q36756837 | ||
| Endocannabinoids and synaptic function in the CNS. | Q36778581 | ||
| Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury | Q36795890 | ||
| A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's disease | Q37025979 | ||
| The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications | Q37029352 | ||
| Integration of metabolism and inflammation by lipid-activated nuclear receptors | Q37225357 | ||
| PPAR Regulation of Inflammatory Signaling in CNS Diseases | Q37231755 | ||
| Endocannabinoid signaling in microglial cells | Q37250243 | ||
| A cortico-hippocampal learning rule shapes inhibitory microcircuit activity to enhance hippocampal information flow. | Q37332501 | ||
| Endocannabinoid-mediated control of synaptic transmission | Q37363621 | ||
| Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling | Q37416400 | ||
| Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons | Q37444504 | ||
| From surface to nuclear receptors: the endocannabinoid family extends its assets | Q37694605 | ||
| Endocannabinoid signaling in neural plasticity | Q37812016 | ||
| Endocannabinoids and retrograde modulation of synaptic transmission | Q37870597 | ||
| The neuropathology and neurobiology of traumatic brain injury | Q38065400 | ||
| The role of markers of inflammation in traumatic brain injury. | Q38086443 | ||
| The clinical spectrum of sport-related traumatic brain injury | Q38088121 | ||
| Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages | Q39990710 | ||
| Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system | Q40115223 | ||
| PPARs in Alzheimer's Disease | Q40288794 | ||
| Retrograde signaling at GABAA-receptor synapses in the mammalian CNS. | Q40372281 | ||
| Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation | Q40437395 | ||
| PPARs in Neuroinflammation | Q41276551 | ||
| Cannabis: pharmacology and toxicology in animals and humans | Q41278775 | ||
| Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells | Q41808335 | ||
| Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury | Q41886732 | ||
| A role for synaptic inputs at distal dendrites: instructive signals for hippocampal long-term plasticity | Q42146426 | ||
| Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients | Q42167232 | ||
| Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation | Q42347749 | ||
| Direct cortical inputs erase long-term potentiation at Schaffer collateral synapses | Q42441869 | ||
| Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains | Q42490661 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. | Q42528169 | ||
| Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. | Q42803428 | ||
| The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. | Q43161568 | ||
| CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients | Q43460178 | ||
| Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease | Q43504648 | ||
| Direct cortical input modulates plasticity and spiking in CA1 pyramidal neurons | Q43965015 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. | Q43999138 | ||
| Endocannabinoids facilitate the induction of LTP in the hippocampus | Q44038905 | ||
| The endogenous cannabinoid system controls extinction of aversive memories | Q44085607 | ||
| Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability | Q44437517 | ||
| Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors | Q44553567 | ||
| Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents | Q44758240 | ||
| Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus | Q44927481 | ||
| Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. | Q44963304 | ||
| RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol | Q44991723 | ||
| Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. | Q45119266 | ||
| Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat | Q45127850 | ||
| Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. | Q45138733 | ||
| A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons | Q45154535 | ||
| CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition | Q45281373 | ||
| Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. | Q46028586 | ||
| Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. | Q46279749 | ||
| High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. | Q46456086 | ||
| Inhibition of perforant path input to the CA1 region by serotonin and noradrenaline | Q46486060 | ||
| A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease | Q46491157 | ||
| Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. | Q46624652 | ||
| Endocannabinoid signaling dynamics probed with optical tools. | Q46750128 | ||
| Impaired spatial representation in CA1 after lesion of direct input from entorhinal cortex | Q46794288 | ||
| Endocannabinoids control the induction of cerebellar LTD. | Q46814707 | ||
| The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines | Q46859038 | ||
| The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells | Q46875092 | ||
| Laminar selectivity of the cholinergic suppression of synaptic transmission in rat hippocampal region CA1: computational modeling and brain slice physiology. | Q48108013 | ||
| Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. | Q48118951 | ||
| P433 | issue | 2 | |
| P921 | main subject | synaptic plasticity | Q1551556 |
| endocannabinoids | Q10483908 | ||
| P304 | page(s) | 152-168 | |
| P577 | publication date | 2014-02-25 | |
| P1433 | published in | The Neuroscientist | Q7753449 |
| P1476 | title | Endocannabinoids in synaptic plasticity and neuroprotection | |
| P478 | volume | 21 |
| Q38579642 | A Comparative Analysis of the Endocannabinoid System in the Retina of Mice, Tree Shrews, and Monkeys |
| Q37625554 | A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells |
| Q48184385 | Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors |
| Q36844731 | Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices. |
| Q50079075 | Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration |
| Q33811998 | Endocannabinoid metabolism in neurodegenerative diseases |
| Q89741164 | Endocannabinoid receptors in the CNS: potential drug targets for the prevention and treatment of neurologic and psychiatric disorders |
| Q42701116 | Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury From SO2 Inhalation via PPARγ Pathway |
| Q28075692 | Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents |
| Q88605567 | First demonstration of in vivo mapping for regional brain monoacylglycerol lipase using PET with [11C]SAR127303 |
| Q49977066 | Glutamatergic, GABAergic, and endocannabinoid neurotransmissions within the dorsal hippocampus modulate the cardiac baroreflex function in rats |
| Q35746303 | Homeostatic regulation of brain functions by endocannabinoid signaling |
| Q46546882 | Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability |
| Q35143497 | Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury. |
| Q47120837 | Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair |
| Q89287054 | Localisation of Formyl-Peptide Receptor 2 in the Rat Central Nervous System and Its Role in Axonal and Dendritic Outgrowth |
| Q37512670 | Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy. |
| Q38555486 | Monoglyceride lipase: Structure and inhibitors. |
| Q27334947 | NO2 inhalation promotes Alzheimer's disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication |
| Q61449859 | Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse |
| Q55255522 | Oxytocin functions as a spatiotemporal filter for excitatory synaptic inputs to VTA dopamine neurons. |
| Q34451684 | Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease. |
| Q41660878 | The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models. |
| Q26765508 | The Endocannabinoid System as a Therapeutic Target in Glaucoma |
| Q59800987 | The Role of Endogenous Neuroprotective Mechanisms in the Prevention of Retinal Ganglion Cells Degeneration |
| Q26768611 | Using Caenorhabditis elegans to Uncover Conserved Functions of Omega-3 and Omega-6 Fatty Acids |
| Q48224703 | mGluR1 enhances efferent inhibition of inner hair cells in the developing rat cochlea. |
Search more.